Arnt J. (1998) Pharmacological differentiation of classical and novel antipsychotics. Int Clin Psychopharmacol 13(SUPPL. 3).
Arnt J., Skarsfeldt T. (1998) Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18:63-101.
Braff D., Stone C., Callaway E., Geyer M.A., Glick I.D., Bali L. (1978) Prestimulus effects of human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343.
Bruhwyler J., Liégeois J.-F., Bergman J., Carey G., Goudie A., Taylor A., Meltzer H., Delarge J., Géczy J. (1997) JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity: A review of its behavioural properties. Pharmacol Res 36:255-264.
Bruhwyler J., Liégeois J.-F., Chleide E., Rogister F., Damas J., Delarge J., Mercier M. (1992) Comparative study of typical neuroleptics, clozapine and newly synthesized clozapine·analogues: Correlations between neurochemistry and behaviour. Behav Pharmacol 3:567-579.
Bruhwyler J., Liégeois J.-F., Lejeune C., Rogister F., Delarge J., Géczy J. (1995) New dibenzazepine derivatives with disinhibitery and/or antidepressant potential: Neurochemical and behavioural study in the open-field and forced swimming tests. Behav Pharmacol 6:830-838.
Casey D.E., Liégeois J.-F., Bruhwyler J., Delarge J., Geczy J. (2001) The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates. Psychopharmacology, in press; .
Cools A.R., Brachten R., Heeren D., Willemen A., Ellenbroek B. (1990) Search after neurobiological profile of individual-specific features of Wistar rats. Brain Res Bull 24:49-69.
Cools A.R., Prinssen E.P., Ellenbroek B.A. (1995) The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: Effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine. Psychopharmacol Berl 119:428-439.
De Hert M., Ellenbroek B. (2000) Animal models of schizophrenia. Neurosci Res Commun 26:279-288.
Depoortere R., Perrault G., Sanger D.J. (1997) Potentiation of prepulse inhibition of the startle reflex in rats: Pharmacological evaluation of the procedure as a model for detecting antipsychotic activity. Psychopharmacol Berl 132:366-374.
Ellenbroek B.A. (1993) Treatment of schizophrenia: A clinical and preclinical evaluation of neuroleptic drugs. Pharmacol Ther 57:1-78.
Ellenbroek B.A., Artz M.T., Cools A.R. (1991) The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine. Eur J Pharmacol 196:103-108.
Ellenbroek B., Cools A.R. (1988) The paw test: An animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism. Life Sci 42:1205-1213.
Ellenbroek B.A., Cools A.R. (2000) Animal models for schizophrenia: An introduction. Atypical Antipsychotics , (Ellenbroek BA and Cools AR eds), Birkhauser Verlag, Basel; 35-53.
Ellenbroek B.A., Lubbers L.J., Cools A.R. (1996) Activity of "seroquel" (ICI 204,636) in animal models for atypical properties of antipsychotics: A comparison with clozapine. Neuropsychopharmacology 15:406-416.
Ellenbroek B.A., Peeters B.W., Honig W.M., Cools A.R. (1987) The paw test: A behavioral paradigm for differentiating between classical and atypical neuroleptic drugs. Psychopharmacol Berl 93:343-348.
Ellenbroek B.A., Prinssen E.P., Cools A.R. (1994) The role of serotonin receptor subtypes in the behavioural effects of neuroleptic drugs. A paw test study in rats. Eur J Neurosci 6:1-8.
Ellenbroek B.A., Sams Dodd F., Cools A.R. (2000) Simulation models for schizophrenia. Atypical Antipsychotics , (Ellenbroek BA and Cools AR eds), Birkhauser Verlag, Basel; 121-141.
Ellenbroek B.A., Van-Den-Kroonenberg P.T.J.M., Cools A.R. (1998) The effects of an early stressful life event on sensorimotor gating in adult rats. Schizophr Res 30:251-260.
Geyer M.A., Markou A. (1995) Animal models of psychiatric disorders. Psychopharmacology: The Fourth Generation of Progress , (Bloom FE and Kupfer DJ eds), Raven Press Ltd., New York; 787-798.
Geyer M.A., Wilkinson L.S., Humby T., Robbins T.W. (1993) Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol Psychiatry 34:361-372.
Goudie A., Taylor A. (1998) Comparative characterisation in the discriminative stimulus properties of clozapine and other antipsychotics in rats. Psychopharmacology 135:392-400.
Invernizzi R., Garavaglia C., Samanin R. (2000) JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity, increases extracellular dopamine in the prefrontal cortex, but not in the striatal and the nucleus accumbens. Naunyn-Schmiedebergs Arch Pharmacol 361:298-302.
Kinney G.G., Wilkinson L.O., Saywell K.L., Tricklebank M.D. (1999) Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J Neurosci 19:5644-5653.
Liégeois J.-F., Bruhwyler J., Petit C., Damas J., Delarge J., Géczy J., Kauffmann J.-M., Lamy M., Meltzer H., Moulthys-Mickalad A. (1999) Oxidation sensitivity may be a useful tool for the detection of the hematotoxic potential of newly developed molecules: Application to antipsychotic drugs. Arch Biochem Biophys 370:126-137.
Liégeois J.-F., Mouithys-Mickalad A., Bruhwyler J., Delarge J., Petit C., Kauffmann J.-M., Lamy M. (1997) JL 13, a potential successor to clozapine is less sensitive to oxidative phenomenons. Biochem Biophys Res Commun 238:252-255.
Liégeois J.-F., Rogister F., Bruhwyler J., Damas J., Nguyen T.P., Inarejos M.-O., Chleide E., Mercier M., Delarge J. (1994) Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potential central nervous system agents: Synthesis and neurochemical study. J Med Chem 37:519-525.
Liégeois J.-F., Zahid N., Bruhwyler J., Uetrecht J. (2000) Hypochlorous acid, a major oxidant produced by activated neutrophils, has low effect on two pyridobenzoazepine derivatives. JL 3 and JL 13. Arch Pharm (Weinbeim) 333:63-67.
Mansbach R.S., Geyer M.A. (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2:299-308.
Mansbach R.S., Geyer M.A., Braff D.L. (1988) Dopaminergic stimulation disrupts se n sorimotor gating in the rat. Psychopharmacol Berl 94:507-514.
Meert T.F., Awouters F. (1991) Serotonin 5HT2 antagonists: A preclinical evaluation of possible therapeutic effects. Serotonin, Sleep and Mental Disorders , (Idzikowski C and Cowen PJ eds), Wrightson Biomedical Publishing, London; 65-76.
Prinssen E.M., Kleven M.S., Koek W. (1999) Interactions between neuroleptics and 5-HT1A ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects. Psychopharmacology 144:20-29.
Schwarzkopf S.B., Bruno J.P., Mitra T. (1993) Effects of haloperidol and SCH 23390 on acoustic startle and prepulse inhibition under basal and stimulated conditions. Prog Neuropsychopharmacol Biol Psychiatry 17:1023-1036.
Sipes T.A., Geyer M.A. (1994) Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33:441-448.
Sipes T.A., Geyer M.A. (1995) 8-OH-DPAT disruption of prepulse inhibition in rats: Reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacol Berl 117:41-48.
Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51:139-154.
Swerdlow N.R., Varty G.B., Geyer M.A. (1998) Discrepant findings of clozapine effects on prepulse inhibition of startle: Is it the route or the rat?. Neuropsychopharmacology 18:50-56.
